Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now?

Omeros Corporation (NASDAQ:OMER) is among the best get rich quick stocks to buy right now. On June 26, Brandon Folkes from H.C. Wainwright trimmed the price target on Omeros Corporation (NASDAQ:OMER) to $33 from $40 and reaffirmed a Buy rating. This price revision follows a “disappointing” negative CHMP opinion for Yartemlea. While the news is likely to weigh on the stock in the near term, the analyst believes it isn’t entirely “thesis-breaking.”

Folkes views the U.S. Yartemlea launch as a key value driver for Omeros Corporation (NASDAQ:OMER). The price cut is based on the firm’s removal of the EU opportunity from its model and the higher R&D spending guidance.

What’s truly impressive is the company’s one-year return. Omeros Corporation (NASDAQ:OMER) delivered a solid return of 200.32% in contrast to the S&P 500’s return of 20.17%. While the company’s year-to-date performance is negative, its upside potential is approximately 374%. With that, OMER is among the best get rich quick stocks to buy right now.

Omeros Corporation (NASDAQ:OMER), incorporated in 1994, is a Washington-based clinical-stage biopharmaceutical company specializing in small-molecule and protein therapeutics.

While we acknowledge the risk and potential of OMER as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OMER and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1